# Oruka Therapeutics, Inc.: Form 8-K, filed Jun 3, 2025

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: 8-K
- Filed: 2025-06-03
- Accepted by EDGAR: Jun 3, 2025, 16:00 ET
- Period: 2025-06-02
- Accession: 0001213900-25-050756
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000121390025050756/ea0244429-8k_oruka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000121390025050756/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000121390025050756/ea0244429-8k_oruka.htm

Filed Jun 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-050756. Last ingested by Listed: Nov 2, 2026, 20:24 ET. No prices; not investment advice.